About Torque Pharmaceuticals Private Limited
Data last updated:
Torque Pharmaceuticals Private Limited is a private limited company based in Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 November 1986 and has been in existence for over 40 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24119CH1986PTC007151. Its GSTIN is 04AABCT1244P3Z9 (Chandigarh). The company holds 23 GST registrations, of which 20 are active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹71.13 Lakh. It was formerly known as Manil Food Processing Company Limited and Manil Organics Private Limited. It is led by directors Amariqbal Singh Bedi (Managing Director) and Mandeep Singh.
Its last annual general meeting (AGM) was held on 30 November 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 693 Phase II Industrial Area, Chandigarh, India – 160002.
As per the financials filed for FY 2024, the company reported a revenue of ₹404.13 Cr, a growth of 1% compared to the previous year. For the same year it recorded a net profit of ₹41.24 Cr (net margin 10.2%) and EBITDA of ₹80.2 Cr (EBITDA margin 19.8%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 3% over five years.
The company has about 1,024 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 2 brands: No Scars and Torque Pharma. As per MCA filings, the company has open charges of ₹266.02 Cr and satisfied charges of ₹68.04 Cr on record. Court records list 274 cases involving the company, including 207 filed by the company and 55 filed against it; 68 cases are pending. The company has 5 deals on record (5 secondary share transfers); the latest was in May 2023. Its 10 peer companies in the Pharma industry (Formulations, Pharmaceuticals) are compared by revenue, 5 larger and 5 smaller; the largest is Themis Medicare Limited with revenue of ₹410.18 Cr. The company has 3 MSME Form 1 returns on record between 2019 and 2020, listing 50 overdue payments to 11 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website torquepharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address693 Phase II Industrial Area, Chandigarh, India – 160002
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Torque Pharmaceuticals Private Limited
The main business activity of Torque Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and food, beverages and tobacco products. 2 activity segments are registered with the MCA.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
| C | Manufacturing | C1 | Food, beverages and tobacco products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Torque Pharmaceuticals Private Limited FY 2024 filings available
Torque Pharmaceuticals Private Limited reported revenue of ₹404.13 Cr (up 1% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Torque Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 3% over five years, including 1% growth in the latest year. EBITDA fell 13% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Torque Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | ₹404.13 Cr | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹80.2 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹41.24 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Torque Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 19.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 10.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Torque Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Torque Pharmaceuticals Private Limited
Torque Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Themis Medicare Limited Listed | ₹410.18 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Vapi, Gujarat, India |
| Skymap Pharmaceuticals Private Limited | ₹409.08 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | New Delhi, Delhi, India |
| Arene Life Sciences (Unit 4) Private Limited | ₹405.87 Cr (FY 2021) | •••• | •••• | 3.0% | •••• | Hyderabad, Telangana, India |
| United Biotech Private Limited | ₹404.94 Cr (FY 2024) | •••• | •••• | 27.0% | •••• | New Delhi, Delhi, India |
| Mascot Health Series Private Limited. | ₹404.31 Cr (FY 2025) | •••• | •••• | 5.0% | •••• | New Delhi, Delhi, India |
| Torque Pharmaceuticals Private Limited this company | ₹404.13 Cr (FY 2024) | •••• | •••• | 1.0% | •••• | Chandigarh, India |
| Steril-Gene Life Sciences Private Limited | ₹404.06 Cr (FY 2025) | •••• | •••• | 41.0% | •••• | Chennai, Tamil Nadu, India |
| Zeiss Pharmaceuticals Private Limited | ₹403.65 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Nalagarh, Himachal Pradesh, India |
| Eisai Pharmaceuticals India Private Limited | ₹402.38 Cr (FY 2025) | •••• | •••• | -15.0% | •••• | Paravada, Andhra Pradesh, India |
| Gland Chemicals Pvt Ltd | ₹401.18 Cr (FY 2022) | •••• | •••• | 33.0% | •••• | Hyderabad, Telangana, India |
| Maiva Pharma Private Limited | ₹399.05 Cr (FY 2025) | •••• | •••• | 38.0% | •••• | Bangalore, Karnataka, India |
Peers are the five companies nearest above and the five nearest below Torque Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Torque Pharmaceuticals Private Limited
Torque Pharmaceuticals Private Limited is audited by S G P N & ASSOCIATES for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| S G P N & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Torque Pharmaceuticals Private Limited
Torque Pharmaceuticals has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mandeep Singh | Director | 05 Nov 2022 | 3 Years 11 Months | Current |
| Amariqbal Singh Bedi Also directs: Kranti Buildwell LLP, Torque Farmer Producer Company Limited, Filmy Keeda Productions Private Limited and 2 more | Managing Director | 23 Aug 1989 | 37 Years 1 Months | Current |
Ownership and Shareholding of Torque Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Torque Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Mar 2025 | Hdfc Bank Limited | ₹17 Cr | Open |
| 30 Apr 2023 | Axis Bank Limited | ₹79.89 Lakh | Open |
| 10 Feb 2023 | Axis Bank Limited | ₹1.49 Cr | Open |
| 06 Jun 2022 | State Bank of India | ₹6.55 Cr | Open |
| 23 Feb 2022 | Axis Bank Limited | ₹2.2 Cr | Open |
Total charge records: 33 View all charges
Deals & Funding of Torque Pharmaceuticals Private Limited
Torque Pharmaceuticals Private Limited has 5 deals on record (5 secondary share transfers); the latest was in May 2023.
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| May 2023 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Nov 2022 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2022 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2018 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 4 individuals |
| Apr 2010 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
Full deal history
All 5 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Torque Pharmaceuticals Private Limited
Torque Pharmaceuticals Private Limited has 274 court cases on record: 207 filed by Torque Pharmaceuticals, 55 filed against it, 12 where it is another party. 68 cases are pending and 206 are disposed. Status as checked between 21 Sep 2026 and 05 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 203 | 30 | 60 |
| High courts | 70 | 25 | 8 |
| Supreme Court | 1 | 0 | 0 |
Cases on record (5 of 274)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Interim or miscellaneous application | Filed against the company by Centaur Pharmaceuticals Private Limited | Pending |
| Bombay High Court | Court case (COMMP) | Filed by the company against Galpha Laboratories Limited. | Pending |
| Bombay High Court | Court case (LPETN) | Filed against the company by Centaur Pharmaceuticals Private Limited | Pending |
| Bombay High Court | Court case (COMIP) | Filed against the company by Centaur Pharmaceuticals Private Limited | Pending |
| Bombay High Court | Court case (CHOL) | Filed against the company by Galpha Laboratories Limited. | Pending |
Full case history
All 274 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Torque Pharmaceuticals Private Limited
Torque Pharmaceuticals Private Limited has 3 MSME Form 1 returns on record between 2019 and 2020, listing 50 overdue payments to 11 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 11)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Sapphire Flexipack Private Limited | •••• | •••• | •••• |
| Indo Pack Limited | •••• | •••• | •••• |
| Talwar Pharma | •••• | •••• | •••• |
| Adani Pharmachem Private Limited | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 3 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Associated Brands with Torque Pharmaceuticals Private Limited
Torque Pharmaceuticals operates two associated brands: No Scars and Torque Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Skincare products including creams and washes for treating scars and improving skin health. | noscars.co.in | |
| Pharmaceutical manufacturing, including tablets, capsules, and exports, with a focus on quality and global distribution. | torquepharma.com |
Employees and EPFO Compliance at Torque Pharmaceuticals Private Limited
Torque Pharmaceuticals Private Limited has a workforce of 1,024 employees as of Jul 23, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Group Structure of Torque Pharmaceuticals Private Limited
Torque Pharmaceuticals has 1 subsidiary company. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares Held |
|---|---|---|
| Filmy Keeda Productions Private Limited | U22212MH2013PTC250561 | Locked |
Showing major subsidiaries. Total: 1.
Name History of Torque Pharmaceuticals Private Limited
Torque Pharmaceuticals has undergone 2 name changes throughout its history. The company was previously known as Manil Food Processing Company Limited, and Manil Organics Private Limited. The current legal name is Torque Pharmaceuticals Private Limited.
| Company Name | Status |
|---|---|
| Torque Pharmaceuticals Private Limited | Current |
| Manil Food Processing Company Limited | Previous |
| Manil Organics Private Limited | Previous |
CIN History of Torque Pharmaceuticals Private Limited
Torque Pharmaceuticals has one previous CIN (Corporate Identification Number): U24230CH1986PTC007151. The current CIN is U24119CH1986PTC007151, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24119CH1986PTC007151 | Current |
| U24230CH1986PTC007151 | Previous |
News related to Torque Pharmaceuticals Private Limited
Recent Activity on Torque Pharmaceuticals Private Limited
Torque Pharmaceuticals Private Limited has 6 board changes on record since 1989: 2 appointments and 4 cessations. The latest: Amariqbal Singh Bedi ceased to be Director on 15 Nov 2022.
55 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Torque Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Torque Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Torque Pharmaceuticals Private Limited
Torque Pharmaceuticals has 23 GST registrations: 20 active and 3 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 04AABCT1244P3Z9 | Chandigarh | Active | 29 Aug 2018 |
| 02AABCT1244P1ZF | Himachal Pradesh | Active | 01 Jul 2017 |
| 03AABCT1244P1ZD | Punjab | Active | 01 Jul 2017 |
| 06AABCT1244P1Z7 | Haryana | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Torque Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Torque Pharmaceuticals Private Limited
Torque Pharmaceuticals is an active private limited company based in Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 November 1986 (40+ years old) and is registered under CIN U24119CH1986PTC007151.
Torque Pharmaceuticals reported revenue of ₹404.13 Cr for FY 2024 (up 1% YoY).
Torque Pharmaceuticals has 2 current directors:
- Amariqbal Singh Bedi - Managing Director
- Mandeep Singh - Director
Torque Pharmaceuticals reported a net profit of ₹41.24 Cr (net margin 10.2%) and EBITDA of ₹80.2 Cr (EBITDA margin 19.8%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Torque Pharmaceuticals is 6% over three years and 3% over five years. In the latest year (FY 2024) revenue rose 1%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Torque Pharmaceuticals is 04AABCT1244P3Z9, registered in Chandigarh. The company has 23 GST registrations in all, of which 20 are active and 3 are cancelled or inactive. Other active GSTINs include 02AABCT1244P1ZF (Himachal Pradesh), 03AABCT1244P1ZD (Punjab), 06AABCT1244P1Z7 (Haryana).
The CIN (Corporate Identification Number) of Torque Pharmaceuticals is U24119CH1986PTC007151. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Torque Pharmaceuticals has 274 court cases on record: 207 filed by the company and 55 filed against it. 68 are pending. Most are in the district courts.
Torque Pharmaceuticals was incorporated on 20 November 1986, making it 40+ years old. It is registered with the Registrar of Companies, Chandigarh.
Torque Pharmaceuticals has 5 deals on record (5 secondary share transfers); the latest was in May 2023.
The peers of Torque Pharmaceuticals by revenue are Themis Medicare Limited, Skymap Pharmaceuticals Private Limited, Arene Life Sciences (Unit 4) Private Limited, United Biotech Private Limited, Mascot Health Series Private Limited. and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Amariqbal Singh Bedi ceased to be Director on 15 Nov 2022. Mandeep Singh was appointed as Director on 05 Nov 2022. Paramjit Singh Chhatwal ceased to be Managing Director on 18 Oct 2022. Torque Pharmaceuticals has 6 board changes on record in total.